Summit Therapeutics summitplc.com


Public list: BIO 2016 (619) Pharma Startups (6570) Rare Diseases (230)

Summit is a biopharmaceutical company focused on the discovery, development and commercialization of medicines for indications for which there are no existing or only inadequate therapies. Summit is conducting clinical programs focused on the genetic disease Duchenne muscular dystrophy and the infectious disease Clostridium difficile infection.

Summit is a biopharmaceutical company focused on the discovery, development and commercialization of medicines for indications for which there are no existing or only inadequate therapies. Summit is conducting clinical programs focused on the genetic...Show all

Company (IPO / Went public)

Phone: +44-123-544-3939

Fax:

136a Eastern Avenue
Milton Park
Abingdon, OX14 4SB
United Kingdom

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Summit Therapeutics $59.2M Jan 14, 2019

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Summit Therapeutics Jobs

jobs by Indeed job
						search
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Antibacterial compounds Mar 08, 2016 Sep 19, 2017 Patent
Compounds for the treatment of clostridium difficile associated disease Jan 29, 2016 Application